129 related articles for article (PubMed ID: 386359)
1. Human carcinoma-associated precursor antigens of the blood group MN system and the host's immune responses to them.
Springer GF; Desai PR; Murthy MS; Tegtmeyer H; Scanlon EF
Prog Allergy; 1979; 26():42-96. PubMed ID: 386359
[No Abstract] [Full Text] [Related]
2. [Antigens associated with human breast carcinoma].
Kriukova IN; Vasilevskaia LN
Vopr Onkol; 1975; 21(2):52-6. PubMed ID: 805495
[No Abstract] [Full Text] [Related]
3. Cross-reacting carcinoma-associated antigens with blood group and precursor specificities.
Springer GF; Desai PR
Transplant Proc; 1977 Mar; 9(1):1105-11. PubMed ID: 68564
[No Abstract] [Full Text] [Related]
4. Adenocarcinoma associated antigen: enhancement of tumor growth with serum from animals bearing adenocarcinoma.
Hakin AA
Surg Forum; 1975; 26():175-7. PubMed ID: 1216104
[No Abstract] [Full Text] [Related]
5. The fundamental and diagnostic role of T and Tn antigens in breast carcinoma at the earliest histologic stage and throughout.
Springer GF; Desai PR; Robinson MK; Tegtmeyer H; Scanlon EF
Prog Clin Biol Res; 1986; 204():47-70. PubMed ID: 2421349
[No Abstract] [Full Text] [Related]
6. Monoclonal antibodies against cell-surface antigens of the metastatic rat 13762NF mammary adenocarcinoma and their cross-reactivity with human breast carcinomas.
North SM; Steck PA; Nicolson GL
Cancer Res; 1986 Dec; 46(12 Pt 1):6393-9. PubMed ID: 3779654
[TBL] [Abstract][Full Text] [Related]
7. Relation of human blood-groups MN to cancer cell surface antigens and to receptors for oncogenic viruses.
Springer GF; Desai PR
Ann Clin Lab Sci; 1974; 4(4):294-8. PubMed ID: 4142544
[TBL] [Abstract][Full Text] [Related]
8. Blood group N antigen precursor glycoproteins and N antigen precursor glycoproteins with Thomsen-Friedenreich (T) activity from human liver metastatic carcinomas.
Otsuka K; Kudo T; Nakajima T; Ohkuma S
Int J Biochem; 1991; 23(5-6):569-78. PubMed ID: 1648519
[TBL] [Abstract][Full Text] [Related]
9. Immunologic and chemotherapeutic parameters in a model breast tumor system.
Rugmann RA; Stolfi RL; Hayworth PE; Martin DS
Cancer Chemother Rep 2; 1974 Mar; 4(1):25-32. PubMed ID: 4826497
[No Abstract] [Full Text] [Related]
10. A B O (H) blood group antigen determination in genitourinary neoplasms.
Ghazizadeh M; Kagawa S
Tokushima J Exp Med; 1983 Jun; 30(1-2):9-16. PubMed ID: 6685361
[No Abstract] [Full Text] [Related]
11. Studies on skin allograft reaction in closed colony black hairy mice previously implanted with selected malignant tumors.
Uchiyama M
Yokohama Med Bull; 1971 Oct; 22(3):49-71. PubMed ID: 4946489
[No Abstract] [Full Text] [Related]
12. Further definition by cytotoxicity tests of cell surface antigens of human sarcomas in culture.
Bloom ET
Cancer Res; 1972 May; 32(5):960-7. PubMed ID: 4502173
[No Abstract] [Full Text] [Related]
13. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
Lopez PF; Parks WP; Lopez DM
J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
[TBL] [Abstract][Full Text] [Related]
14. Immune response to inactivated syngeneic mammary adenocarcinoma cells. II. Parameters of immunogenicity in DBA/2 mice.
DeLustro F; Haskill JS
J Natl Cancer Inst; 1980 Jan; 64(1):131-7. PubMed ID: 6928038
[No Abstract] [Full Text] [Related]
15. Delayed cutaneous hypersensitivity reactions to membrane extracts of carcinomatous cells of the cervix uteri.
Wells SA; Melewicz FC; Christiansen C; Ketcham AS
Surg Gynecol Obstet; 1973 May; 136(5):717-20. PubMed ID: 4701902
[No Abstract] [Full Text] [Related]
16. The development of cellular immunity to tumor cells.
Cerilli J; Smith MC
Surg Gynecol Obstet; 1972 May; 134(5):739-45. PubMed ID: 5064081
[No Abstract] [Full Text] [Related]
17. Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens.
Hand PH; Nuti M; Colcher D; Schlom J
Cancer Res; 1983 Feb; 43(2):728-35. PubMed ID: 6848188
[TBL] [Abstract][Full Text] [Related]
18. Cycling of immune responses to a syngeneic murine mammary adenocarcinoma.
Huber SA; Bigi G; Lucas ZJ
Cancer Res; 1980 Oct; 40(10):3484-90. PubMed ID: 6449282
[No Abstract] [Full Text] [Related]
19. [Solubilization of antigens from ATPC+ ascitic tumor using hypertonic sodium solution].
Marconi P; Bistoni F; Pitzurra M
Boll Soc Ital Biol Sper; 1973 May; 49(10):534-8. PubMed ID: 4132962
[No Abstract] [Full Text] [Related]
20. Carcinoma-associated blood group MN precursor antigens against which all humans possess antibodies.
Springer GF; Desai PR; Yang HJ; Murthy MS
Clin Immunol Immunopathol; 1977 May; 7(3):426-41. PubMed ID: 68842
[No Abstract] [Full Text] [Related]
[Next] [New Search]
